SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
McEwen Inc. issued a press release on August 5, 2026, disclosing its second quarter 2026 financial and operating results, including net income of $9.6M ($0.16 per share) versus $3.0M ($0.06 per share) in Q2 2025, along with material operational updates on production guidance, project development, and exploration results. This is a standard quarterly earnings release filed under Item 2.02 and furnished as Exhibit 99.1.
View raw filing on EDGAR →This is a press release announcing unaudited consolidated financial results for Q2 2026 and the six-month period ended June 30, 2026. The exhibit discloses revenue ($14.6M in Q2, $26.9M in H1), net income ($4.0M in Q2, $5.1M in H1), Adjusted EBITDA ($9.1M in Q2, $15.3M in H1), and earnings per share ($0.19 in Q2, $0.24 in H1), with detailed comparative analysis against prior-year periods. This is a discrete earnings announcement, not a periodic financial report filing.
View raw filing on EDGAR →Fluor Corporation announced its financial results for the quarter ended June 30, 2026, via a press release attached as Exhibit 99.1. The disclosure includes Q2 2026 highlights with revenue of $4.3 billion (up 9% y/y), GAAP net earnings of $114 million, EPS of $0.81, new awards of $6.1 billion, and ending backlog of $26.9 billion. This is a standard quarterly earnings release with comprehensive financial metrics and business segment performance data, clearly falling under Item 2.02 (Results of Operations and Financial Condition).
View raw filing on EDGAR →This is a press release announcing United Maritime's second quarter and first half 2026 financial results, including net revenues of $10.0 million (Q2) and $17.9 million (6M), net income of $1.2 million (Q2) and $1.0 million (6M), and adjusted EBITDA of $5.2 million (Q2) and $8.4 million (6M). The document explicitly states "United Maritime Reports Second Quarter and First Half 2026 Financial Results" and presents comprehensive financial tables and metrics. While the release also discusses strategic fleet repositioning and dividend declaration, the primary disclosure is the quarterly and interim financial results, which is the hallmark of an earnings_release.
View raw filing on EDGAR →This is a press release announcing B2Gold's Q2 2026 operational and financial results, including gold production (203,648 ounces), consolidated cash operating costs ($1,201/oz), all-in sustaining costs ($2,356/oz), and net income of $417 million ($0.31 per share). The document explicitly states "B2Gold Reports Q2 2026 Results" and presents detailed financial and operational metrics for the quarter, which is the hallmark of an earnings release. Material to investors as it discloses quarterly financial performance and updated full-year guidance.
View raw filing on EDGAR →This is a press release announcing Tenaris's 2026 second quarter and first half financial results, with detailed income statements, cash flow analysis, and segment performance. The filing explicitly states "This report contains Tenaris's Press Release announcing 2026 Second Quarter Results" and includes comprehensive quarterly and six-month financial data, making it a classic earnings release disclosure material to investors.
View raw filing on EDGAR →Johnson Outdoors issued a press release on August 7, 2026 announcing third fiscal quarter results ending July 3, 2026, with detailed financial metrics including net sales of $189.7 million (up 5%), net income of $14.9 million ($1.42 per diluted share), and year-to-date results. The filing explicitly states the press release is being furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard disclosure vehicle for quarterly earnings releases.
View raw filing on EDGAR →This is a clear earnings release disclosing United-Guardian's second quarter and first-half 2026 financial results. The filing includes a press release (Exhibit 99.1) with detailed income statements showing net sales increased 10% in Q2 and 12% for the six-month period, with net income up 16% and 30% respectively. The disclosure is material to investors as it reports quarterly operating performance and earnings per share.
View raw filing on EDGAR →Algonquin Power & Utilities Corp. disclosed Q2 2026 financial results, reporting net earnings of $0.01 per share and Adjusted Net Earnings of $0.04 per share, along with six-month results and business segment performance for the three and six months ended June 30, 2026.
View raw filing on EDGAR →This is a straightforward earnings release for the second quarter ended June 30, 2026. The Item 2.02 disclosure explicitly states "the Company issued a press release announcing its financial results for the quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The exhibit contains detailed quarterly financial results including gross premiums written, combined ratio, net income, and earnings per share, along with management commentary on performance. This is a material disclosure affecting investor assessment of the registrant's financial condition.
View raw filing on EDGAR →The 8-K discloses a press release (Exhibit 99.1) announcing IEH Corporation's quarterly financial results for the quarter ended June 30, 2026. The release highlights record revenue of $10.02M (59% increase YoY), operating profit of $664,802 (vs. prior-year loss), net income of $654,466 (vs. prior-year loss), and record backlog of $40M. This is a classic earnings release disclosure under Item 9.01, material to investors assessing the registrant's financial performance and trajectory.
View raw filing on EDGAR →Entera Bio disclosed financial results for the three months ended June 30, 2026, reporting a net loss of $7.3 million ($0.14 per share), cash position of $11.3 million, R&D expenses of $3.2 million, and G&A expenses of $1.4 million.
View raw filing on EDGAR →Goldman Sachs BDC issued a press release on August 6, 2026 announcing its financial results for the second quarter ended June 30, 2026, including net investment income per share of $0.38, NAV per share of $12.06, and portfolio composition details.
View raw filing on EDGAR →This is a press release announcing Wheaton Precious Metals' second quarter 2026 financial results, including record revenue of $929 million, net earnings of $543 million, and operating cash flow of $650 million for Q2, as well as record year-to-date figures. The document explicitly states "Wheaton Precious Metals Announces Second Quarter 2026 Results" and provides detailed operational and financial metrics typical of a quarterly earnings disclosure.
View raw filing on EDGAR →The 6-K announces that KEPCO plans to disclose "preliminary unaudited consolidated earnings results for the first half of 2026" on August 12, 2026, and will hold a conference call to discuss those results. This is a notice of an imminent earnings announcement for H1 2026 financial results, which constitutes material disclosure of periodic financial performance to investors.
View raw filing on EDGAR →This is a press release announcing unaudited consolidated financial results for the first half-year ended June 30, 2026. The exhibit discloses key financial metrics including revenue (RMB 14.7 billion, up 13.9% YoY), gross profit (up 36.5%), operating profit (up 58.9%), and earnings per share (RMB 14.94 basic, up 53.2% YoY), along with operational highlights such as engine unit sales (277,684 units, up 10.9%). This is a discrete earnings announcement, not a periodic financial report filing itself, and represents material financial performance information that would affect a reasonable investor's assessment of the company.
View raw filing on EDGAR →ARKO Corp. issued a press release on August 7, 2026, announcing financial results for the second quarter ended June 30, 2026, including net income of $9.4 million and Adjusted EBITDA of $72.0 million, along with segment performance metrics and full-year guidance reaffirmation.
View raw filing on EDGAR →Canopy Growth issued a press release on August 7, 2026 announcing financial results for its fiscal first quarter ended June 30, 2026. The disclosure includes consolidated net revenue of $81.2M (13% growth), segment-level revenue breakdowns, gross margin improvements, adjusted EBITDA metrics, and net loss comparisons—all hallmarks of a quarterly earnings release. Item 2.02 explicitly covers "Results of Operations and Financial Condition," and the attached Exhibit 99.1 is the earnings press release itself.
View raw filing on EDGAR →This is a clear earnings release disclosing Wendy's financial results for Q2 2026 (quarter ended June 28, 2026), including revenue of $571 million, net income of $32.6 million, and adjusted EBITDA of $124.1 million. The press release is furnished as Exhibit 99.1 under Item 2.02, which is the standard Item for earnings disclosures. The filing also includes material forward guidance changes (withdrawal of 2026 outlook) and a dividend reduction, but the core event is the quarterly earnings announcement.
View raw filing on EDGAR →This is a clear earnings release disclosing Minerva Neurosciences' financial results for the quarter ended June 30, 2026. The Item 2.02 section explicitly states the company "issued a press release regarding its financial results for the quarter ended June 30, 2026," with the press release furnished as Exhibit 99.1. The exhibit contains detailed quarterly and six-month financial results including R&D expense, G&A expense, net income/loss, cash position, and per-share metrics, along with business updates on the Phase 3 roluperidone trial and scientific advisory board formation.
View raw filing on EDGAR →This is a clear earnings release disclosing Gyre Therapeutics' financial results for Q2 2026 and year-to-date results, including revenues of $29.1 million for Q2 and $53.5 million for six months, GAAP basic EPS of $(0.12), and detailed operating expense breakdowns. The press release is furnished as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition), which is the standard Item for earnings disclosures.
View raw filing on EDGAR →The filing discloses second quarter 2026 financial results for Atossa Therapeutics through a press release dated August 7, 2026, attached as Exhibit 99.1. The disclosure includes operating expenses ($8.7M for Q2 2026), R&D expenses ($4.9M), G&A expenses ($3.8M), and interest income ($0.2M), along with comparisons to prior-year periods and detailed breakdowns of expense categories. This is a standard quarterly earnings release for a clinical-stage biopharmaceutical company, material to investors assessing the company's financial position and cash burn rate.
View raw filing on EDGAR →CBL & Associates Properties reported its second quarter 2026 financial results on August 6, 2026, with the earnings release and supplemental financial information attached as Exhibit 99.1. The disclosure includes consolidated statements of operations, FFO reconciliations, balance sheet data, and detailed operational metrics. This is a standard quarterly earnings release disclosing results of operations and financial condition under Item 2.02.
View raw filing on EDGAR →BCB Bancorp disclosed Q2 2026 financial results via an earnings conference call held on August 3, 2026, with the transcript furnished as Exhibit 99.1. The Item 2.02 disclosure explicitly references "results of the second quarter ended June 30, 2026" and includes discussion of earnings per share, net loss (including a $5.3 million goodwill write-off), net interest margin, capital levels, and credit quality metrics. This is a standard earnings release disclosure material to investors assessing the registrant's financial performance.
View raw filing on EDGAR →Global Self Storage disclosed its financial results for the second quarter and first half ended June 30, 2026, via an earnings press release. The disclosure includes Q2 and first-half 2026 highlights, detailed financial summaries, same-store results, operating results, FFO and AFFO metrics, and management commentary on operational performance, occupancy, tenant duration, and capital resources.
View raw filing on EDGAR →BCP Investment Corporation issued a press release on August 6, 2026, announcing its financial results for the fiscal quarter ended June 30, 2026, disclosing net investment income of $5.5 million ($0.45 per share), NAV of $179.5 million ($14.49 per share), and portfolio composition details. This is a standard quarterly earnings release filed under Item 2.02 with exhibits 99.1 and 99.2 attached, which is material to investors assessing the registrant's financial performance and condition.
View raw filing on EDGAR →The 8-K Item 8.01 discloses the transcript of Liquidity Services' earnings conference call held on August 6, 2026, presenting Q3 fiscal 2026 financial results. The call includes detailed discussion of GAAP diluted EPS of $0.32 (up 39% YoY), GMV growth of 10% to $453 million, revenue growth of 8% to $129.6 million, and Adjusted EBITDA growth of 30% to $22 million, along with segment-level performance and forward guidance for Q4 2026. This is a standard earnings release disclosure furnished as an exhibit.
View raw filing on EDGAR →This exhibit is a press release announcing Emera Inc.'s 2026 second quarter financial results, disclosing Q2 2026 adjusted EPS of $0.69 and reported EPS of $0.34, along with year-to-date results and segment performance. The document explicitly states "Emera Reports 2026 Second Quarter Financial Results" and provides detailed financial metrics, segment results, and forward-looking guidance, which are hallmarks of an earnings release.
View raw filing on EDGAR →This exhibit is a press release announcing Purple Biotech's second quarter 2026 financial results, including condensed consolidated interim financial statements for the three and six months ended June 30, 2026. The disclosure includes R&D and G&A expenses, operating loss, net income/loss, cash position ($6.1 million), and cash runway through mid-2027. While the company is clinical-stage and pre-revenue, the financial results and cash runway disclosure are material to investors assessing the registrant's financial condition and ability to fund operations.
View raw filing on EDGAR →This 6-K furnishes a webcast presentation and operational highlights for Petrobras's 2Q26 performance, disclosing financial results including net income of US$10.4 billion, EBITDA of US$18.6 billion, and operating cash flow of US$12.3 billion, along with production records (3.34 MMboed) and operational metrics. The document explicitly references "2Q26 Performance" and presents quarterly financial and operational results comparable to a press release announcing earnings, making it an earnings_release rather than a periodic financial report.
View raw filing on EDGAR →Under Armour issued a press release on August 7, 2026 announcing unaudited financial results for the first quarter of fiscal 2027 ended June 30, 2026, including revenue of $1.1 billion (down 3%), gross margin of 54.1%, net income of $1 million, and diluted EPS of $0.00. The company also updated its full-year fiscal 2027 revenue outlook to expect a mid-single-digit decline (versus prior slight decline) while maintaining profitability guidance. This is a standard quarterly earnings disclosure with material updates to forward guidance.
View raw filing on EDGAR →aTyr Pharma issued a press release on August 7, 2026 announcing second quarter 2026 financial results, including condensed consolidated statements of operations and balance sheets. The filing discloses Q2 2026 R&D expenses of $6.7 million, G&A expenses of $4.1 million, net loss of $10.3 million, and cash position of $58.9 million as of June 30, 2026. This is a standard quarterly earnings release furnished under Item 2.02.
View raw filing on EDGAR →This is a clear earnings release disclosing quarterly financial results for Q2 2026 (ended June 30, 2026), including condensed consolidated balance sheets, statements of operations, and comprehensive loss. The Item 2.02 disclosure explicitly states "On May 8, 2026, Kiora Pharmaceuticals, Inc. (the 'Company') issued a press release announcing financial results for the quarter ended March 31, 2026 and an update on clinical development progress," with the full press release attached as Exhibit 99.1. The filing includes detailed financial tables and operating metrics typical of an earnings announcement.
View raw filing on EDGAR →This is a clear earnings release disclosing Rapid Micro Biosystems' second quarter 2026 financial results. The Item 2.02 filing explicitly states the company "issued a press release announcing its financial results for its second quarter ended June 30, 2026," with the press release attached as Exhibit 99.1. The disclosure includes detailed quarterly revenue ($8.1M, up 11% YoY), gross margin (15%, a record), net loss ($12.9M), and full-year 2026 guidance reaffirmation—all hallmarks of a standard quarterly earnings announcement.
View raw filing on EDGAR →Dorchester Minerals disclosed quarterly financial results for Q2 2026 (period ended June 30, 2026) via press release dated August 6, 2026, reporting net income of $30,871,000 ($0.62 per common unit) and operating revenues of $56,075,000, with comparative results for Q2 2025 and year-to-date periods.
View raw filing on EDGAR →Gray Media issued a press release on August 7, 2026 reporting financial results for the three and six-month periods ended June 30, 2026, including revenue of $839 million (Q2) and $1,607 million (YTD), net income of $14 million (Q2) and net loss of $6 million (YTD), and Adjusted EBITDA of $214 million (Q2) and $368 million (YTD). The release also announces a new $250 million debt repurchase authorization. This is a standard quarterly earnings disclosure furnished under Item 2.02, material to investors assessing the company's operational and financial performance.
View raw filing on EDGAR →Nathan's Famous issued a press release on August 7, 2026 announcing financial results for its first fiscal quarter ended June 28, 2026, disclosing revenues of $54.1 million, net income of $8.8 million, and diluted EPS of $2.14 per share compared to prior-year results. The entire press release is attached as Exhibit 99.1 and incorporated by reference, which is the standard format for earnings releases under Item 2.02.
View raw filing on EDGAR →Geospace Technologies issued a press release on August 6, 2026, announcing operating results for Q3 fiscal year 2026, disclosing revenue of $15.8 million (down from $24.8 million year-ago), a net loss of $9.7 million or $(0.75) per diluted share (versus net income of $0.06 per share in Q3 2025), and nine-month results showing a net loss of $30.5 million or $(2.37) per diluted share. This is a standard earnings release disclosure under Item 2.02, material to investors assessing the registrant's financial performance and operational trends.
View raw filing on EDGAR →The filing discloses that RGC Resources is hosting a conference call to discuss "operating results of the Company's third quarter ending June 30, 2026," with presentation materials furnished as Exhibit 99.1. This is a disclosure of quarterly financial results, which qualifies as an earnings release despite being filed under Item 7.01 (Regulation FD Disclosure) rather than the more typical Item 2.02. The substance—disclosure of Q3 operating results—is material to investors.
View raw filing on EDGAR →This is a straightforward earnings release for Q2 2026 ended June 30, 2026. The Item 2.02 disclosure explicitly states "Ultralife Corporation issued a press release regarding the financial results for its second quarter ended June 30, 2026," with the full press release attached as Exhibit 99.1. The release reports key financial metrics including revenue ($47.9M), gross profit ($13.9M), operating income ($3.4M), net income ($2.5M), and EPS ($0.15), along with segment performance and forward guidance. This is a material quarterly earnings disclosure typical of Item 2.02 filings.
View raw filing on EDGAR →Essent Group Ltd. issued a press release on August 7, 2026 announcing its financial results for the quarter ended June 30, 2026, disclosing net income of $189.7 million or $2.08 per diluted share. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings releases. The disclosure includes comprehensive financial statements, segment results, and key operational metrics.
View raw filing on EDGAR →The 8-K discloses Earth Science Tech's fiscal first quarter 2027 financial results via a press release filed as Exhibit 99.1 under Item 2.02 (Results of Operations and Financial Condition). The release reports net income growth of 57% year-over-year to $715,697, diluted EPS tripling to $0.003, and operating cash flow growth of 108%, along with significant share repurchases of 3.7 million shares. These are material financial results that would affect a reasonable investor's assessment of the company's performance and financial condition.
View raw filing on EDGAR →This is a quarterly earnings release for Q2 2026 disclosing financial results and business highlights. The press release (Exhibit 99.1) reports revenue of $1.5 million for Q2 2026 (19% increase YoY), net loss of $3.4 million, and detailed operational metrics including 216% YoY growth in CyPath Lung test volume. The filing is structured as Item 2.02 with the press release attached as Exhibit 99.1, which is the standard format for earnings disclosures on Form 8-K.
View raw filing on EDGAR →Parks! America, Inc. disclosed its third fiscal quarter financial results for the 13 and 39 weeks ended June 28, 2026 via a news release issued on August 7, 2026, filed under Item 2.02 (Results of Operations and Financial Condition). The filing includes detailed segment-level revenue, operating income, and financial condition data across the company's three regional safari parks, along with consolidated financial metrics and a conference call announcement.
View raw filing on EDGAR →This is a press release announcing Alps Group Inc's fiscal year 2026 financial results for the year ended March 31, 2026. The exhibit discloses revenue growth of 44% to $4.9 million, net loss of $2.1 million, and includes detailed consolidated financial statements (income statement, balance sheet, and cash flow statement). The company explicitly states it "announced its financial results for the year ended March 31, 2026" and references its filed Form 20-F annual report. This is a discrete earnings announcement, not the periodic report itself.
View raw filing on EDGAR →The 8-K discloses financial results for Q2 2026 under Item 2.02 (Results of Operations and Financial Condition). The filing includes a press release (Exhibit 99.1) announcing second-quarter financial results, with detailed operating metrics, balance-sheet data, and net loss figures. The company also held an investor webcast on August 7, 2026 to discuss results and corporate developments, which is a standard earnings-release disclosure pattern.
View raw filing on EDGAR →The 8-K discloses a press release announcing the date and time of a conference call to discuss the Company's second quarter 2026 financial results, with results to be released pre-market on August 14, 2026. Although the actual financial results are not yet disclosed in this filing, the announcement of the earnings release date and conference call is a standard earnings-release disclosure under Item 7.01 (Regulation FD Disclosure), and the attached press release explicitly states the company "plans to release its financial results for the second quarter ended June 30, 2026, pre-market on Friday, August 14, 2026."
View raw filing on EDGAR →The filing discloses second-quarter 2026 financial results for Plains All American Pipeline and Plains GP Holdings, including net income of $1.830 billion, Adjusted EBITDA of $738 million, and operating cash flow of $956 million. The press release (Exhibit 99.1) presents comprehensive quarterly results with detailed financial tables, segment performance, and forward guidance, which is the hallmark of an earnings release under Item 2.02.
View raw filing on EDGAR →This 6-K furnishes a press release announcing GRAVITY's unaudited financial results for the second quarter ended June 30, 2026, including detailed revenue, operating profit, and net profit figures alongside consolidated financial statements and business updates. The disclosure explicitly states "GRAVITY REPORTS SECOND QUARTER OF 2026 RESULTS AND BUSINESS UPDATES" and presents quarterly comparative metrics (QoQ and YoY), making it a discrete earnings announcement rather than a periodic financial report.
View raw filing on EDGAR →This is a press release announcing Docebo's second quarter 2026 financial results, disclosing subscription revenue of $63.8 million (12% YoY growth), total revenue of $68.7 million (13% YoY growth), net income of $2.3 million, and adjusted EBITDA of $11.2 million. The document includes detailed financial highlights, customer wins, and updated full-year 2026 guidance, all characteristic of a quarterly earnings release. Material to investors assessing the company's financial performance and trajectory.
View raw filing on EDGAR →